Bharat Biotech Expects Peer Review of Covaxin's Phase 3 Trials Data in Q4 2021

Bharat Biotech said there were nine publications on Covaxin so far and the efficacy paper of phase-3 trials would be the tenth one.

from Top Business News- News18.com https://ift.tt/3ze702a